Aurinia Pharmaceuticals
AUPH
#4603
Rank
ยฃ1.55 B
Marketcap
ยฃ11.77
Share price
0.38%
Change (1 day)
64.36%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): ยฃ63.06 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ0.26 Billion. In 2024 the company made an earning of ยฃ9.22 Million, an increase over its 2023 earnings that were of -ยฃ56.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ63.06 M583.94%
2024 ยฃ9.22 M-116.44%
2023 -ยฃ56.07 Million-31.8%
2022 -ยฃ82.22 Million-39.4%
2021 -ยฃ0.14 Billion61.9%
2020 -ยฃ83.8 Million-9.73%
2019 -ยฃ92.83 Million92.65%
2018 -ยฃ48.19 Million36.39%
2017 -ยฃ35.33 Million106.29%
2016 -ยฃ17.13 Million-15.4%
2015 -ยฃ20.25 Million65.84%
2014 -ยฃ12.21 Million129.82%
2013 -ยฃ5.32 Million-26.6%
2012 -ยฃ7.24 Million
2010 -ยฃ4.1 Million-39.22%
2009 -ยฃ6.75 Million-43.78%
2008 -ยฃ11.99 Million-53.19%
2007 -ยฃ25.62 Million42.97%
2006 -ยฃ17.92 Million-23.03%
2005 -ยฃ23.28 Million36.1%
2004 -ยฃ17.11 Million172.57%
2003 -ยฃ6.28 Million484.61%
2002 -ยฃ1.08 Million
2000 -ยฃ5.1 Million453.81%
1999 -ยฃ0.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
ยฃ3.86 B 6,020.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-ยฃ4.12 Million-106.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-ยฃ16.61 Million-126.31%๐Ÿ‡บ๐Ÿ‡ธ USA